candidate for endoscopic sinus surgery. During endoscopic examination
Conditions
Interventions
Intervention 1: Intervention group 1: Magnesium sulfate infusion 50 mg/kg/ min for 10 min and then 15 mg/kg/h to the end of surgery. Intervention 2: Intervention group 2: Dexmedetomidine infusion 1 mi
Treatment - Drugs
Intervention group 1: Magnesium sulfate infusion 50 mg/kg/ min for 10 min and then 15 mg/kg/h to the end of surgery.
Intervention group 2: Dexmedetomidine infusion 1 micg/kg/ min for 10 min and then 0.5 micg/kg/h to the end of surgery.
Sponsors
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients candidate for endoscopic sinus surgery; age of 18 to 60 years. Exclusion criteria: Obesity with BMI index equal to or greater than 30; renal, liver, hematological, neuromuscular or hemorrhagic disorders; diabetes; using calcium blocker or NSAIDS.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measuring bleeding. Timepoint: at 1, 5, 15, 30 and 60 minutes after starting infusion. Method of measurement: using suction. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahdi Shahabi Nejad
Besat Hospital
Outcome results
None listed